世界のモルシドミン市場インサイト・予測(~2027)

QYResearchが発行した調査報告書(QY21AUG3991)
◆英語タイトル:Global Molsidomine Market Insights and Forecast to 2027
◆商品コード:QY21AUG3991
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年8月(※2024年版があります。お問い合わせください。)
◆ページ数:99
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはモルシドミンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。モルシドミンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(錠剤、エアロゾル)、用途別市場規模(病院、薬局、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・モルシドミンの世界市場概要
・メーカー別の競争状況、市場シェア
・モルシドミンの種類別市場規模:錠剤、エアロゾル
・モルシドミンの用途別市場規模:病院、薬局、その他
・北米のモルシドミン市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパのモルシドミン市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアのモルシドミン市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米のモルシドミン市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカのモルシドミン市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:AdvaCare、China Resources Double-Crane Pharmaceutical Co., Ltd.、Shanghai Zhonghua Pharmaceutical Co., Ltd.、Beijing Hyderun Pharmaceutical Group Co., Ltd.、Heilongjiang Fulekang Pharmaceutical Co., Ltd.、Taj Life Sciences、Sanofi
・モルシドミンのバリューチェーン・販売チャネル分析
・モルシドミンの世界市場動向
【レポートの概要】

Molsidomine is a vasodilator drug,Is a vasodilator drug and used for the prevention and long-term treatment of stable and unstable angina pectoris, with or without left heart failure. It is also used to treat angina in the context of an acute myocardial infarction.

Market Analysis and Insights: Global Molsidomine Market
The global Molsidomine market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Molsidomine Scope and Segment
Molsidomine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Molsidomine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Tablet
Aerosol

Segment by Application
Hospital
Pharmacy
Others

By Company
AdvaCare
China Resources Double-Crane Pharmaceutical Co., Ltd.
Shanghai Zhonghua Pharmaceutical Co., Ltd.
Beijing Hyderun Pharmaceutical Group Co., Ltd.
Heilongjiang Fulekang Pharmaceutical Co., Ltd.
Taj Life Sciences
Sanofi

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

【レポートの目次】

1 Study Coverage
1.1 Molsidomine Product Introduction
1.2 Market by Type
1.2.1 Global Molsidomine Market Size Growth Rate by Type
1.2.2 Tablet
1.2.3 Aerosol
1.3 Market by Application
1.3.1 Global Molsidomine Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Molsidomine Sales Estimates and Forecasts 2016-2027
2.2 Global Molsidomine Revenue Estimates and Forecasts 2016-2027
2.3 Global Molsidomine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Molsidomine Regions by Sales
2.4.1 Global Top Molsidomine Regions by Sales (2016-2021)
2.4.2 Global Top Molsidomine Regions by Sales (2022-2027)
2.5 Global Top Molsidomine Regions by Revenue
2.5.1 Global Top Molsidomine Regions by Revenue (2016-2021)
2.5.2 Global Top Molsidomine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Molsidomine Sales by Manufacturers
3.1.1 Global Top Molsidomine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Molsidomine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Molsidomine Sales in 2020
3.2 Global Molsidomine Revenue by Manufacturers
3.2.1 Global Top Molsidomine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Molsidomine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Molsidomine Revenue in 2020
3.3 Global Molsidomine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Molsidomine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Molsidomine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Molsidomine Sales by Type
4.1.1 Global Molsidomine Historical Sales by Type (2016-2021)
4.1.2 Global Molsidomine Forecasted Sales by Type (2022-2027)
4.1.3 Global Molsidomine Sales Market Share by Type (2016-2027)
4.2 Global Molsidomine Revenue by Type
4.2.1 Global Molsidomine Historical Revenue by Type (2016-2021)
4.2.2 Global Molsidomine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Molsidomine Revenue Market Share by Type (2016-2027)
4.3 Global Molsidomine Price by Type
4.3.1 Global Molsidomine Price by Type (2016-2021)
4.3.2 Global Molsidomine Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Molsidomine Sales by Application
5.1.1 Global Molsidomine Historical Sales by Application (2016-2021)
5.1.2 Global Molsidomine Forecasted Sales by Application (2022-2027)
5.1.3 Global Molsidomine Sales Market Share by Application (2016-2027)
5.2 Global Molsidomine Revenue by Application
5.2.1 Global Molsidomine Historical Revenue by Application (2016-2021)
5.2.2 Global Molsidomine Forecasted Revenue by Application (2022-2027)
5.2.3 Global Molsidomine Revenue Market Share by Application (2016-2027)
5.3 Global Molsidomine Price by Application
5.3.1 Global Molsidomine Price by Application (2016-2021)
5.3.2 Global Molsidomine Price Forecast by Application (2022-2027)

6 North America
6.1 North America Molsidomine Market Size by Type
6.1.1 North America Molsidomine Sales by Type (2016-2027)
6.1.2 North America Molsidomine Revenue by Type (2016-2027)
6.2 North America Molsidomine Market Size by Application
6.2.1 North America Molsidomine Sales by Application (2016-2027)
6.2.2 North America Molsidomine Revenue by Application (2016-2027)
6.3 North America Molsidomine Market Size by Country
6.3.1 North America Molsidomine Sales by Country (2016-2027)
6.3.2 North America Molsidomine Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Molsidomine Market Size by Type
7.1.1 Europe Molsidomine Sales by Type (2016-2027)
7.1.2 Europe Molsidomine Revenue by Type (2016-2027)
7.2 Europe Molsidomine Market Size by Application
7.2.1 Europe Molsidomine Sales by Application (2016-2027)
7.2.2 Europe Molsidomine Revenue by Application (2016-2027)
7.3 Europe Molsidomine Market Size by Country
7.3.1 Europe Molsidomine Sales by Country (2016-2027)
7.3.2 Europe Molsidomine Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Molsidomine Market Size by Type
8.1.1 Asia Pacific Molsidomine Sales by Type (2016-2027)
8.1.2 Asia Pacific Molsidomine Revenue by Type (2016-2027)
8.2 Asia Pacific Molsidomine Market Size by Application
8.2.1 Asia Pacific Molsidomine Sales by Application (2016-2027)
8.2.2 Asia Pacific Molsidomine Revenue by Application (2016-2027)
8.3 Asia Pacific Molsidomine Market Size by Region
8.3.1 Asia Pacific Molsidomine Sales by Region (2016-2027)
8.3.2 Asia Pacific Molsidomine Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Molsidomine Market Size by Type
9.1.1 Latin America Molsidomine Sales by Type (2016-2027)
9.1.2 Latin America Molsidomine Revenue by Type (2016-2027)
9.2 Latin America Molsidomine Market Size by Application
9.2.1 Latin America Molsidomine Sales by Application (2016-2027)
9.2.2 Latin America Molsidomine Revenue by Application (2016-2027)
9.3 Latin America Molsidomine Market Size by Country
9.3.1 Latin America Molsidomine Sales by Country (2016-2027)
9.3.2 Latin America Molsidomine Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Molsidomine Market Size by Type
10.1.1 Middle East and Africa Molsidomine Sales by Type (2016-2027)
10.1.2 Middle East and Africa Molsidomine Revenue by Type (2016-2027)
10.2 Middle East and Africa Molsidomine Market Size by Application
10.2.1 Middle East and Africa Molsidomine Sales by Application (2016-2027)
10.2.2 Middle East and Africa Molsidomine Revenue by Application (2016-2027)
10.3 Middle East and Africa Molsidomine Market Size by Country
10.3.1 Middle East and Africa Molsidomine Sales by Country (2016-2027)
10.3.2 Middle East and Africa Molsidomine Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 AdvaCare
11.1.1 AdvaCare Corporation Information
11.1.2 AdvaCare Overview
11.1.3 AdvaCare Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AdvaCare Molsidomine Product Description
11.1.5 AdvaCare Recent Developments
11.2 China Resources Double-Crane Pharmaceutical Co., Ltd.
11.2.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Corporation Information
11.2.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Overview
11.2.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Molsidomine Product Description
11.2.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments
11.3 Shanghai Zhonghua Pharmaceutical Co., Ltd.
11.3.1 Shanghai Zhonghua Pharmaceutical Co., Ltd. Corporation Information
11.3.2 Shanghai Zhonghua Pharmaceutical Co., Ltd. Overview
11.3.3 Shanghai Zhonghua Pharmaceutical Co., Ltd. Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Shanghai Zhonghua Pharmaceutical Co., Ltd. Molsidomine Product Description
11.3.5 Shanghai Zhonghua Pharmaceutical Co., Ltd. Recent Developments
11.4 Beijing Hyderun Pharmaceutical Group Co., Ltd.
11.4.1 Beijing Hyderun Pharmaceutical Group Co., Ltd. Corporation Information
11.4.2 Beijing Hyderun Pharmaceutical Group Co., Ltd. Overview
11.4.3 Beijing Hyderun Pharmaceutical Group Co., Ltd. Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Beijing Hyderun Pharmaceutical Group Co., Ltd. Molsidomine Product Description
11.4.5 Beijing Hyderun Pharmaceutical Group Co., Ltd. Recent Developments
11.5 Heilongjiang Fulekang Pharmaceutical Co., Ltd.
11.5.1 Heilongjiang Fulekang Pharmaceutical Co., Ltd. Corporation Information
11.5.2 Heilongjiang Fulekang Pharmaceutical Co., Ltd. Overview
11.5.3 Heilongjiang Fulekang Pharmaceutical Co., Ltd. Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Heilongjiang Fulekang Pharmaceutical Co., Ltd. Molsidomine Product Description
11.5.5 Heilongjiang Fulekang Pharmaceutical Co., Ltd. Recent Developments
11.6 Taj Life Sciences
11.6.1 Taj Life Sciences Corporation Information
11.6.2 Taj Life Sciences Overview
11.6.3 Taj Life Sciences Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Taj Life Sciences Molsidomine Product Description
11.6.5 Taj Life Sciences Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Molsidomine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Sanofi Molsidomine Product Description
11.7.5 Sanofi Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Molsidomine Value Chain Analysis
12.2 Molsidomine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Molsidomine Production Mode & Process
12.4 Molsidomine Sales and Marketing
12.4.1 Molsidomine Sales Channels
12.4.2 Molsidomine Distributors
12.5 Molsidomine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Molsidomine Industry Trends
13.2 Molsidomine Market Drivers
13.3 Molsidomine Market Challenges
13.4 Molsidomine Market Restraints

14 Key Findings in The Global Molsidomine Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

AdvaCare、China Resources Double-Crane Pharmaceutical Co., Ltd.、Shanghai Zhonghua Pharmaceutical Co., Ltd.、Beijing Hyderun Pharmaceutical Group Co., Ltd.、Heilongjiang Fulekang Pharmaceutical Co., Ltd.、Taj Life Sciences、Sanofi

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のモルシドミン市場インサイト・予測(~2027)(Global Molsidomine Market Insights and Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。